JUN 28, 2017 12:01 PM PDT

Stem Cells Treat Asthma?

WRITTEN BY: Kara Marker

A new treatment for chronic asthma could help people who don’t respond to the standard corticosteroids, who don't have any other options. A new breed of stem cells appears to be the answer, cells capable of reversing the negative effects of asthma on lung tissue.

The new approach to treating chronic asthma is based on induced pluripotent stem cell-derived mesenchymal stem cells (MSCs) from Cynata Therapeutics, an Australian “clinical-stage stem cell and regenerative medicine company.”

What are induced pluripotent stem cells, and what makes them a promising component of a new asthma treatment? These types of stem cells can be directly acquired from adult stem cells and can differentiate (transform into) other types of cells, such as lung cells to recharge lung tissue damaged from chronic asthma.

From Monash University in Australia, researchers tested the therapeutic effect of MSCs - delivered intranasally - in a model of experimental asthma, examining their influence on three components of asthma: inflammation, airway remodeling, airway hyperresponsiveness (the classic symptom of asthma). How effective are MSCs at treating these components? Quite. MSCs reduced inflammation, reversed negative effects of airway remodeling, and returned lung tissue scarring and hyperresponsiveness back to its normal state.

"When we've tested other types of stem cells they haven't been able to fully reverse scarring and lung dysfunction associated with asthma - we've had to combine them with anti-scarring drugs to achieve that,” explained lead researcher Chrishan Samuel. “These cells were remarkable on their own as they were able to effectively reverse the scarring that contributes to lung dysfunction and difficulty in breathing.”

Turned into a new treatment option, MSCs could either provide a new chance for asthma patients not responding to standard corticosteroid therapy or a completely new treatment for people who simply want another choice. In the future, MSCs as an asthma treatment will be tested in comparison to and in combination with standard corticosteroid treatments.

The present study was published in the FASEB Journal.

Source: Monash University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 05, 2021
Immunology
Immune Imbalances Dictate COVID Symptom Severity
JAN 05, 2021
Immune Imbalances Dictate COVID Symptom Severity
COVID symptoms. “As it is often the case for pathogenic infections, the host immune system is a key player in vira ...
JAN 28, 2021
Neuroscience
Immune Cells Destroy Synapses in Multiple Sclerosis
JAN 28, 2021
Immune Cells Destroy Synapses in Multiple Sclerosis
Researchers from Germany have found that Multiple sclerosis (MS)-associated inflammation in the cerebral cortex destroys ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 09, 2021
Immunology
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
MAR 09, 2021
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenz ...
MAR 18, 2021
Immunology
"Brainwashed" Immune Cells Help Breast Tumors Thrive
MAR 18, 2021
"Brainwashed" Immune Cells Help Breast Tumors Thrive
Immunologists have discovered a mechanism through which immune cells get recruited into breast cancer tumors, and instea ...
APR 22, 2021
Drug Discovery & Development
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
APR 22, 2021
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
Researchers from Johns Hopkins have found that the mRNA Covid vaccines developed by Pfizer and Moderna not only work wit ...
Loading Comments...